Start your weight loss journey now ! 📞 240-540-5585
ADVANCED SOLUTIONS FOR EFFECTIVE WEIGHT LOSS
SEMAGLUTIDE
SEMAGLUTIDE
SEMAGLUTIDE
SEMAGLUTIDE is a long-acting FDA-approved injectable medication specifically designed for weight management in adults struggling with overweight or obesity. It effectively reduces appetite, curtails cravings, and promotes healthier eating habits. By supporting sustained weight loss and improving associated medical conditions like diabetes and hypertension, Semaglutide offers a safe and proven solution for long-term weight control.
TIRZEPATIDE
SEMAGLUTIDE
SEMAGLUTIDE
TIRZEPATIDE is a groundbreaking dual-action molecule that activates the body's GIP and GLP-1 receptors—natural incretin hormones critical for appetite regulation and fat metabolism. Found in key areas of the brain, these receptors play a vital role in suppressing hunger, reducing food intake, and enhancing fat utilization. Clinical studies have shown Tirzepatide's remarkable ability to facilitate significant weight loss, improve blood sugar levels, and boost overall metabolic health, making it a promising option for individuals seeking comprehensive weight management.
How SEMAGLUTIDE & TIRZEPATIDE SuppoRT WEIGHT LOSS
Tirzepatide and Semaglutide are revolutionary GLP-1 receptor agonists designed to assist your weight loss journey naturally and safely. These medications work by reducing hunger and appetite helping you control cravings and make healthier food choices. They also improve satiety, allowing you to feel full longer with smaller portions, which helps in reducing calorie intake.
In addition, Tirzepatide and Semaglutide decrease mental focus on food, making it easier to resist unnecessary snacking and emotional overeating. They also stimulate fat oxidation encouraging your body to burn stored fat more efficiently as a source of energy.
Experience a more balanced approach to weight management with these advanced treatments — designed to support sustainable weight loss by regulating appetite, enhancing satiety, and promoting fat burning.
Contact us today to learn how Tirzepatide or Semaglutide can help you achieve your health goals effectively.
SEMAGLUTIDE vs TIRZEPATIDE
Which medication is right for you?
Semaglutide and Tirzepatide are innovative medications used for managing type 2 diabetes and weight loss, but they have key differences in their composition and mechanisms of action.
SEMAGLUTIDE is a GLP-1 (glucagon-like peptide-1) analog that helps reduce appetite, slow stomach emptying, and improve blood sugar control, thus facilitating weight loss and diabetes management.
TIRZEPATIDE is a dual agonist that acts on both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 receptor. This combined action further enhances appetite reduction, blood sugar control, and weight loss, potentially offering more effective results compared to semaglutide alone.
SUMMARY
Semaglutide focuses on regulating appetite and glucose via the GLP-1 pathway while Tirzepatide leverages the combined action of GIP and GLP-1 for a more potent, multisystem intervention. The choice between the two medications will depend on individual needs and medical advice
BENEFITS OF SEMAGLUTIDE & TIRZEPATIDE FOR WEIGHT LOSS
✅ SIGNIfICANT WEIGHT REDUCTION
Help lose up to 15% or more of body weight when combined with diet and exercise.
✅ APPETITE SUPPRESSION
Reduce hunger and cravings, making calorie control easier.
✅ INCREASED SATIETY
Feel full longer after meals, supporting sustainable weight management.
✅ BLOOD SUGAR IMPROVEMENT
Assist in controlling blood sugar levels, lowering diabetes risk.
✅ LONG-TERM RESULTS
Designed for safe, effective, and lasting weight loss under medical supervision.
✅ HEALTH RISK REDUCTION
Lower blood pressure, cholesterol, and decrease cardiovascular disease risk.
SUCCESS RATES
SEMAGLUTIDE: A study published in the International Journal of Obesity showed that patients achieved a Total Body Weight Loss of 5.7% at three, 9.7% at six , 12.7% at nine , and 13.4% at 12 months, with 22% of patients achieving weight loss of >20%.
TIRZEPATIDE: Adults with obesity receiving TIrzepatide lost a mean 25.3% of body weight at 88 weeks in the SURMOUNT-4 Trial.
More than half of Tirzepatide participants lost 25% or more body weight at 88 weeks.
EWEIGHT MEDICAL CENTER
VIRTUAL SERVICES
Telehealth or Online visits available in the following STATES:
Arizona, Colorado, Delaware, Iowa, Maine, Maryland, Massachussetts, Montana, New Jersey, New Mexico, North Dakota, South Dakota, Utah, Virginia, West Virginia and Wyoming
SEMAGLUTIDE $299/MOnth or TIRZEPATIDE $399/month
One Free BODY CONTOURING with purchase of 5 mos package of GLP-1 ($500 value). Promo ends on February 28, 2026